Edward E. Schweizer

9.9k total citations
264 papers, 7.4k citations indexed

About

Edward E. Schweizer is a scholar working on Organic Chemistry, Plant Science and Experimental and Cognitive Psychology. According to data from OpenAlex, Edward E. Schweizer has authored 264 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Organic Chemistry, 69 papers in Plant Science and 51 papers in Experimental and Cognitive Psychology. Recurrent topics in Edward E. Schweizer's work include Weed Control and Herbicide Applications (53 papers), Organophosphorus compounds synthesis (45 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (40 papers). Edward E. Schweizer is often cited by papers focused on Weed Control and Herbicide Applications (53 papers), Organophosphorus compounds synthesis (45 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (40 papers). Edward E. Schweizer collaborates with scholars based in United States, United Kingdom and Spain. Edward E. Schweizer's co-authors include Karl Rickels, Robert L. Zimdahl, Thomas A. Albright, Walter Freeman, Cathryn M. Clary, Donald W. Lybecker, W G Case, Jay D. Amsterdam, Ira Fox and Karl Rickels and has published in prestigious journals such as Science, Journal of the American Chemical Society and American Journal of Psychiatry.

In The Last Decade

Edward E. Schweizer

259 papers receiving 6.7k citations

Peers

Edward E. Schweizer
Bernard J. Carroll United States
Lucien C. Manchester United States
Dun‐Xian Tan United States
Patricia A. Zunszain United Kingdom
Dun‐Xian Tan United States
Vivette Glover United Kingdom
Edward E. Schweizer
Citations per year, relative to Edward E. Schweizer Edward E. Schweizer (= 1×) peers Daniel P. Cardinali

Countries citing papers authored by Edward E. Schweizer

Since Specialization
Citations

This map shows the geographic impact of Edward E. Schweizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward E. Schweizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward E. Schweizer more than expected).

Fields of papers citing papers by Edward E. Schweizer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward E. Schweizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward E. Schweizer. The network helps show where Edward E. Schweizer may publish in the future.

Co-authorship network of co-authors of Edward E. Schweizer

This figure shows the co-authorship network connecting the top 25 collaborators of Edward E. Schweizer. A scholar is included among the top collaborators of Edward E. Schweizer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward E. Schweizer. Edward E. Schweizer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kasper, Siegfried, et al.. (2013). How well do randomized controlled trial data generalize to ‘real-world’ clinical practice settings? A comparison of two generalized anxiety disorder studies. European Neuropsychopharmacology. 24(1). 125–132. 7 indexed citations
2.
Pettinati, Helen M., et al.. (2011). Efficacy of Extended-Release Naltrexone in Patients with Relatively Higher Severity of Alcohol Dependence. Alcoholism Clinical and Experimental Research. 35(10). 1804–1811. 19 indexed citations
3.
Meyer, Jonathan M., Antony Loebel, & Edward E. Schweizer. (2009). Lurasidone: a new drug in development for schizophrenia. Expert Opinion on Investigational Drugs. 18(11). 1715–1726. 110 indexed citations
4.
Rickels, Karl, et al.. (1999). Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmacology. 141(1). 1–5. 59 indexed citations
5.
Amsterdam, Jay D., Felipe García‐España, Jan Fawcett, et al.. (1998). Efficacy and Safety of Fluoxetine in Treating Bipolar II Major Depressive Episode. Journal of Clinical Psychopharmacology. 18(6). 435–440. 128 indexed citations
6.
Rickels, Karl, et al.. (1997). Gepirone and Diazepam in Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 17(4). 272–277. 48 indexed citations
7.
Schweizer, Edward E., Richard J. Thielen, & Alan Frazer. (1997). Venlafaxine:a novel antidepressant compound. Expert Opinion on Investigational Drugs. 6(1). 65–78. 29 indexed citations
8.
Rickels, Karl, Albert Derivan, Nadia R. Kunz, Allan Pallay, & Edward E. Schweizer. (1996). Zalospirone in Major Depression. Journal of Clinical Psychopharmacology. 16(3). 212–217. 16 indexed citations
9.
Freeman, Ellen W., Karl Rickels, Edward E. Schweizer, & Tracy V. Ting. (1995). Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychological Medicine. 25(2). 309–315. 55 indexed citations
10.
Rickels, Karl & Edward E. Schweizer. (1993). Anxiolytics: Indications, Benefits, and Risks of Short and Long-Term Benzodiazepine Therapy: Current Research Data. PsycEXTRA Dataset. 131. 51–67. 3 indexed citations
11.
Schweizer, Edward E., William M. Patterson, Karl Rickels, & M. Rosenthal. (1992). A ONCE-A-DAY, SLOW-RELEASE FORM OF ALPRAZOLAM FOR THE TREATMENT OF PANIC DISORDER: A PLACEBO-CONTROLLED STUDY. Clinical Neuropharmacology. 15. 26B–26B. 1 indexed citations
12.
Rickels, Karl, Edward E. Schweizer, & W G Case. (1992). BENZODIAZEPINES: TOLERANCE AND WITHDRAWAL: THE CLINICIANʼS POINT OF VIEW. Clinical Neuropharmacology. 15. 102A–103A. 2 indexed citations
13.
Schweizer, Edward E. & Philip Westra. (1991). Potential for Weeds to Develop Resistance to Sugar Beet Herbicides in North America. Journal of Sugarbeet Research. 28(1&2). 1–22. 2 indexed citations
14.
Schweizer, Edward E.. (1991). Carbamazepine Treatment in Patients Discontinuing Long-term Benzodiazepine Therapy. Archives of General Psychiatry. 48(5). 448–448. 95 indexed citations
15.
Ruppel, E. G., R. J. Hecker, & Edward E. Schweizer. (1982). Rhizoctonia Root Rot of Sugarbeet Unaffected by Herbicides. Journal of Sugarbeet Research. 21(3). 201–209. 2 indexed citations
16.
Schweizer, Edward E., et al.. (1982). りん化合物の反応 XL トリフェニルホスホニウム2‐〔(2‐オキソ‐1,2‐ジフェニルエチリデン)ヒドラゾノ〕プロピリドのアルキル化およびアシル化 ベンゾイル化による異例なピリダジンおよびピラゾール生成物の試験. The Journal of Organic Chemistry. 47(14). 2768–2773. 17 indexed citations
17.
Rice, Robert W., et al.. (1980). WSC volume 28 issue 2 Cover and Front matter. Weed Science. 28(2). f1–f2. 1 indexed citations
18.
Schweizer, Edward E. & Y. Eshel. (1978). Response of Sugarbeets (Beta Vulgaris) and Annual Weeds to Mefluidide. Journal of Sugarbeet Research. 20(2). 147–165.
19.
Schweizer, Edward E.. (1971). Herbicidal activitiy of chloroacetamides and pyridazinones on sugarbeets and weeds. Journal of Sugarbeet Research. 16(5). 359–368. 2 indexed citations
20.
Schweizer, Edward E., et al.. (1968). Herbicidal control of weeds in sugarbeet. Journal of Sugarbeet Research. 15(3). 263–276. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026